Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 5/20 | 0.41 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.40 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.40 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.34 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31135220 | 1.00 | SLC5A2 (0.41) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL7149673 | 0.90 | TXNRD1 (0.40) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL7616740 | 0.90 | SLC5A2 (0.42) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL29306309 | 0.90 | TXNRD1 (0.40) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL8084789 | 0.90 | TXNRD1 (0.40) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL13590060 | 0.90 | SLC5A2 (0.45) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL2384795 | 0.90 | SLC5A2 (0.45) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL10590087 | 0.90 | SLC5A2 (0.45) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL24579840 | 0.89 | SLC5A2 (0.41) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 | |
| SCHEMBL7151167 | 0.89 | SLC5A2 (0.41) | SLC5A2TXNRD1TXNRD3TXNRD2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025202306-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS GMBH (AT) | 2025-10-02 | — | — | WO | claimed |
| EP-4473055-B1 | POLYOLEFIN BLEND CONTAINING RECYCLED ALUMINIUM | INEOS EUROPE AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20260085177-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS AG (AT) | 2026-03-26 | — | — | US | disclosed |
| EP-3461859-B1 | REINFORCED POLYMER COMPOSITION | BOREALIS GMBH (AT) | 2026-01-21 | — | — | EP | disclosed |
| EP-3180399-B1 | TERPOLYMER COMPOSITIONS WITH IMPROVED CLARITY AND GLOSS | EQUISTAR CHEM LP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20260001976-A1 | A PROPYLENE-ETHYLENE RANDOM COPOLYMER FOR PIPE APPLICATIONS | BOREALIS AG (AT) | 2026-01-01 | — | — | US | disclosed |
| WO-2025202306-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS GMBH (AT) | 2025-10-02 | — | — | WO | disclosed |
| US-12415912-B2 | Filled polypropylene (PP) compositions with improved thermo-mechanical properties | BOREALIS AG (AT) | 2025-09-16 | — | — | US | disclosed |
| US-20250263545-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | BOREALIS AG (AT) | 2025-08-21 | — | — | US | disclosed |
| US-20250250400-A1 | A PROCESS FOR RECYCLING POLYPROPYLENE FILMS | BOREALIS AG (AT) | 2025-08-07 | — | — | US | disclosed |
| US-11332603-B2 | Polypropylene composition with excellent surface appearance | BOREALIS AG (AT) | 2022-05-17 | — | — | US | disclosed |
| US-20220145055-A1 | PROCESS FOR PREPARING A POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2022-05-12 | — | — | US | disclosed |
| US-20220073718-A1 | RANDOM PROPYLENE POLYMER COMPOSITION AND USE IN EXTRUSION BLOW MOULDING | BOREALIS AG (AT) | 2022-03-10 | — | — | US | disclosed |
| US-11230637-B2 | Soft polypropylene composition with improved properties | BOREALIS AG (AT) | 2022-01-25 | — | — | US | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085177-A1 | POLYPROPYLENE COMPOSITION FOR CABLE INSULATION | MPC2, CRHR2, NPY2R | SLC5A2 1422/4885TXNRD1 267/4885TXNRD3 248/4885 |
| US-20260001976-A1 | A PROPYLENE-ETHYLENE RANDOM COPOLYMER FOR PIPE APPLICATIONS | PEX3, MPC2, LBR | SLC5A2 2500/4885TXNRD1 1924/4885TXNRD3 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.